Skip to main content
Fig.1 | Cell Communication and Signaling

Fig.1

From: Correction: LOX overexpression programming mediates the osteoclast mechanism of low peak bone mass in female offspring rats caused by pregnant dexamethasone exposure

Fig.1

(uncorrected) PDE induced low peak bone mass and hyperactivation of osteoclast function in female adult offspring rats. A Representative micro-CT images in each group of rats. B-E Quantification analyses of all bone sections, including BV/TV, Tb.N, Tb.Th, Tb.Sp. F Representative images of TRAP staining in decalcified bone sections of adult offspring rats. G Quantification analyses of N.Oc/B.Pm. H Quantification analyses of Oc.S/BS. I-N NFATc1, c-Fos, Acp5, CtsK, Oscar, and DC-stamp mRNA expression in bone tissue of adult offspring rats. O Correlation analysis between NFATc1 mRNA expression and BV/TV. Mean ± S.E.M., n = 8 per group for micro-CT, mRNA expression and correlation analysis, n = 3 per group for TRAP staining. *P < 0.05, **P < 0.01 vs. Control. #P < 0.05, ##P < 0.01 vs. PDE. PDE: prenatal dexamethasone exposure; BV/TV: bone volume per tissue volume; Tb.N: trabecula number; Tb.Th: trabecular thickness; Tb.Sp: trabecula separation; TRAP: tartrate-resistant acid phosphatase; N.Oc/B.Pm: osteoclast number per bone perimeter; Oc.S/BS: osteoclast surface per bone surface; NFATc1: nuclear factor of active T cells 1; c-Fos: protooncogene c-Fos; Acp5: acid phosphatase 5; CtsK: cathepsin K; Oscar: osteoclast-associated receptor; DC-stamp: dendritic cell-specific transmembrane protein; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; YWHAZ: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta

Back to article page